A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Shattuck Labs, Inc.
National Cancer Institute (NCI)
Checkpoint Therapeutics, Inc.
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Fate Therapeutics
Incyte Corporation
Celgene
Pfizer
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Celldex Therapeutics
Mirna Therapeutics, Inc.
Rutgers, The State University of New Jersey
Seagen Inc.
National Cancer Institute (NCI)
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)